How should I evaluate and manage a woman with vaginal discharge to diagnose and treat bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis, and atrophic vaginitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis and Treatment of Vaginitis

Immediate Diagnostic Approach

Order a wet prep with pH testing at the point of care, combined with NAAT testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis to ensure comprehensive diagnosis. 1

Critical Timing for Wet Prep

  • Examine the wet prep within 30 minutes to 2 hours of collection, as motile trichomonads lose viability and become undetectable after this window 2, 1
  • Collect vaginal swabs from pooled vaginal discharge or lateral vaginal walls, avoiding cervical mucus contamination 2

Three-Component Wet Prep Examination

Saline Wet Mount:

  • Look for clue cells (bacterial-covered epithelial cells indicating bacterial vaginosis) 3, 1
  • Identify motile flagellated trichomonads (though sensitivity is only 40-80%, hence the need for NAAT) 2
  • Count white blood cells (elevated in trichomoniasis and inflammatory conditions) 1

10% KOH Preparation:

  • Visualize pseudohyphae and budding yeast for candidiasis diagnosis 1, 4
  • Perform the "whiff test" - a fishy amine odor indicates bacterial vaginosis 3, 1

Vaginal pH Testing:

  • pH <4.5 suggests vulvovaginal candidiasis 2, 1
  • pH >4.5 indicates bacterial vaginosis or trichomoniasis 3, 2, 1

Bacterial Vaginosis

Diagnosis

Use the Amsel criteria, requiring 3 of 4 findings: 3, 5, 4

  • Homogeneous white discharge that smoothly coats vaginal walls 3
  • Vaginal pH >4.5 3
  • Positive whiff test (fishy odor with 10% KOH) 3
  • Clue cells on microscopy 3

While Gram stain (Nugent criteria) is the gold standard laboratory method, it is not required for routine clinical diagnosis when Amsel criteria can be applied 3, 1

Treatment for Non-Pregnant Women

First-line therapy: Oral metronidazole 500 mg twice daily for 7 days 6, 5, 4

Alternative regimens: 6, 5

  • Intravaginal metronidazole gel
  • Oral or intravaginal clindamycin cream

For recurrent bacterial vaginosis (multiple documented recurrences):

  • Use longer courses of therapy 5

Follow-up:

  • Unnecessary if symptoms resolve 6
  • Patients should return only if symptoms recur 6

Treatment in Pregnancy

All symptomatic pregnant women must be tested and treated because bacterial vaginosis is associated with premature rupture of membranes, preterm labor, preterm birth, and postpartum endometritis 6

Recommended treatment: 6

  • Oral metronidazole or clindamycin

Mandatory follow-up:

  • Perform follow-up evaluation one month after treatment completion to verify therapeutic effectiveness due to risk of adverse pregnancy outcomes 6

Vulvovaginal Candidiasis (VVC)

Classification

Uncomplicated VVC: 6

  • Sporadic or infrequent episodes
  • Mild to moderate symptoms
  • Likely caused by Candida albicans
  • Present in nonimmunocompromised women

Complicated VVC: 6

  • Recurrent (4 or more episodes per year) 5
  • Severe symptoms
  • Caused by non-albicans Candida species
  • Present in pregnant women or those with uncontrolled diabetes, debilitation, or immunosuppression

Diagnosis

  • Clinical presentation: pruritus, erythema in vulvovaginal area, white discharge 6
  • Vaginal pH <4.5 (normal) 6, 2
  • 10% KOH preparation showing yeasts or pseudohyphae 6, 1
  • Culture is mandatory for recurrent infections to identify non-albicans species requiring different treatment 2, 1

Treatment for Uncomplicated VVC

Short-course topical azoles (single dose or 1-3 days) achieve 80-90% cure rates: 6

Intravaginal options include: 6

  • Clotrimazole 1% cream 5g for 7-14 days
  • Clotrimazole 100mg tablet for 7 days
  • Clotrimazole 500mg tablet, single dose
  • Miconazole 2% cream 5g for 7 days
  • Terconazole 0.4% cream 5g for 7 days
  • Terconazole 0.8% cream 5g for 3 days

Oral option:

  • Fluconazole 150mg single dose 6

Important caveat: Oil-based creams and suppositories may weaken latex condoms and diaphragms 6

Treatment for Complicated/Recurrent VVC

Initial therapy:

  • Longer duration of therapy required to achieve remission 6

Maintenance therapy (after initial remission):

  • Weekly oral fluconazole for up to 6 months 5
  • Alternative maintenance regimens include clotrimazole, ketoconazole, or itraconazole for 6 months 6

Treatment in Pregnancy

Only 7-day topical azole therapies are recommended for pregnant women 6

  • Oral fluconazole is contraindicated in pregnancy 6

Trichomoniasis

Diagnosis

NAAT testing is essential because wet mount microscopy has only 40-80% sensitivity and requires examination within 30 minutes to 2 hours 2, 1

Recommended diagnostic approach: 2, 1, 4

  • NAAT for Trichomonas vaginalis (superior sensitivity)
  • Antigen testing using immunoassay
  • DNA probe testing

Clinical findings: 6

  • Diffuse, malodorous, yellow-green discharge
  • Vulvar irritation
  • Vaginal pH >4.5 2
  • Red punctate lesions on cervix (strawberry cervix) 1

Treatment for Non-Pregnant Women

Recommended regimens (90-95% cure rates): 6, 5

  • Oral metronidazole 2g single dose
  • OR oral metronidazole 500mg twice daily for 7 days

Both regimens are equally effective 5

Partner treatment:

  • Treat all sex partners, even without screening, to enhance cure rates 6, 5
  • Patients should avoid sex until both partners are cured 6

For treatment-resistant cases:

  • Higher-dose therapy may be needed 5

Follow-up:

  • Test of cure is not recommended for initially asymptomatic patients who become asymptomatic after treatment 6, 5

Treatment in Pregnancy

Symptomatic pregnant women should be treated to relieve symptoms and prevent preterm birth, premature rupture of membranes, and low birthweight 6

Recommended treatment:

  • Oral metronidazole 2g single dose 6

Safety note:

  • Multiple studies and meta-analyses have not demonstrated consistent association between metronidazole use during pregnancy and teratogenic or mutagenic effects 6

Atrophic Vaginitis

Diagnosis

  • Results from estrogen deficiency 7
  • Presents with vaginal dryness, irritation, dyspareunia 4
  • Vaginal pH typically elevated 4

Treatment

  • Topical estrogen therapy is effective 7
  • Nonhormonal therapies are alternative options 4

Critical Pitfalls to Avoid

Never rely solely on wet mount for Trichomonas - sensitivity is only 40-80% and requires living organisms examined within 30 minutes to 2 hours 2

Don't assume normal pH excludes all infections - yeast typically has pH <4.5, while bacterial vaginosis and trichomoniasis have pH >4.5 2

Don't delay wet mount examination beyond 2 hours if using this method, as organisms lose motility and become undetectable 2, 1

Culture is not recommended for bacterial vaginosis diagnosis because G. vaginalis can be isolated from half of normal women, lacking specificity 3

Always order NAAT testing simultaneously with wet prep - microscopy alone has significant limitations for detecting all three major causes of infectious vaginitis 2, 1

References

Guideline

Diagnostic Approach for Vaginal Discharge

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Room Temperature Stability of Liquid Amies Media for Vaginal Pathogen Detection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bacterial Vaginosis Diagnosis Using Wet Prep and Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vaginitis: Diagnosis and Treatment.

American family physician, 2018

Research

Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of vaginitis.

American family physician, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.